- Home
- Publications
- Publication Search
- Publication Details
Title
Checkpoint Nano‐PROTACs for Activatable Cancer Photo‐Immunotherapy
Authors
Keywords
-
Journal
ADVANCED MATERIALS
Volume -, Issue -, Pages 2208553
Publisher
Wiley
Online
2022-11-26
DOI
10.1002/adma.202208553
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Light‐Triggered Efficient Sequential Drug Delivery of Biomimetic Nanosystem for Multimodal Chemo‐, Antiangiogenic, and Anti‐MDSC Therapy in Melanoma
- (2022) Xing Lai et al. ADVANCED MATERIALS
- Delivery strategies in treatments of leukemia
- (2022) Tianyuan Ci et al. CHEMICAL SOCIETY REVIEWS
- PROTAC targeted protein degraders: the past is prologue
- (2022) Miklós Békés et al. NATURE REVIEWS DRUG DISCOVERY
- Regulating trained immunity with nanomedicine
- (2022) Mandy M. T. van Leent et al. Nature Reviews Materials
- Activatable cancer sono‐immunotherapy using semiconducting polymer nanobodies
- (2022) Ziling Zeng et al. ADVANCED MATERIALS
- Protease-Responsive Peptide-Conjugated Mitochondrial-Targeting AIEgens for Selective Imaging and Inhibition of SARS-CoV-2-Infected Cells
- (2022) Yong Cheng et al. ACS Nano
- Catalytical nano-immunocomplexes for remote-controlled sono-metabolic checkpoint trimodal cancer therapy
- (2022) Chi Zhang et al. Nature Communications
- Beyond conventional immune-checkpoint inhibition — novel immunotherapies for renal cell carcinoma
- (2021) David A. Braun et al. Nature Reviews Clinical Oncology
- Semiconducting polymer nano-PROTACs for activatable photo-immunometabolic cancer therapy
- (2021) Chi Zhang et al. Nature Communications
- PROTACs technology for targeting non-oncoproteins: Advances and perspectives
- (2021) Chao Wang et al. BIOORGANIC CHEMISTRY
- Targeted Protein Degradation through Fast Optogenetic Activation and Its Application to the Control of Cell Signaling
- (2021) Amy Ryan et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Aptamer-Based Logic Computing Reaction on Living Cells to Enable Non-Antibody Immune Checkpoint Blockade Therapy
- (2021) Yu Yang et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Smart Nano‐PROTACs Reprogram Tumor Microenvironment for Activatable Photo‐metabolic Cancer Immunotherapy
- (2021) Chi Zhang et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Semiconducting Polymer Nano‐regulators with Cascading Activation for Photodynamic Cancer Immunotherapy
- (2021) Shasha He et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- A Dual‐Color Fluorescent Probe Allows Simultaneous Imaging of Main and Papain‐like Proteases of SARS‐CoV‐2‐Infected Cells for Accurate Detection and Rapid Inhibitor Screening
- (2021) Yong Cheng et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Hallmarks of response, resistance, and toxicity to immune checkpoint blockade
- (2021) Golnaz Morad et al. CELL
- T lymphocyte membrane-decorated epigenetic nanoinducer of interferons for cancer immunotherapy
- (2021) Yihui Zhai et al. Nature Nanotechnology
- Top 10 Challenges in Cancer Immunotherapy
- (2020) Priti S. Hegde et al. IMMUNITY
- Improving cancer immunotherapy using nanomedicines: progress, opportunities and challenges
- (2020) John D. Martin et al. Nature Reviews Clinical Oncology
- Dual pH-sensitive nanodrug blocks PD-1 immune checkpoint and uses T cells to deliver NF-κB inhibitor for antitumor immunotherapy
- (2020) Zecong Xiao et al. Science Advances
- Allosteric inhibition of SHP2 stimulates anti-tumor immunity by transforming the immunosuppressive environment
- (2020) Elsa Quintana et al. CANCER RESEARCH
- Immune checkpoint signaling and cancer immunotherapy
- (2020) Xing He et al. CELL RESEARCH
- Targeting pulmonary tumor microenvironment with CXCR4-inhibiting nanocomplex to enhance anti–PD-L1 immunotherapy
- (2020) Zhaoting Li et al. Science Advances
- Targeted Degradation of Transcription Coactivator SRC‐1 through the N‐Degron Pathway
- (2020) Yeongju Lee et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Challenges and Opportunities in Cancer Drug Resistance
- (2020) Richard A. Ward et al. CHEMICAL REVIEWS
- Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors
- (2020) Lorenzo Galluzzi et al. Nature Reviews Clinical Oncology
- Proton-driven transformable nanovaccine for cancer immunotherapy
- (2020) Ningqiang Gong et al. Nature Nanotechnology
- Targeted degradation of immune checkpoint proteins: emerging strategies for cancer immunotherapy
- (2020) Jie Xu et al. ONCOGENE
- Activatable Polymer Nanoenzymes for Photodynamic Immunometabolic Cancer Therapy
- (2020) Ziling Zeng et al. ADVANCED MATERIALS
- Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance
- (2019) Filipe Martins et al. Nature Reviews Clinical Oncology
- Checkpoint blockade and nanosonosensitizer-augmented noninvasive sonodynamic therapy combination reduces tumour growth and metastases in mice
- (2019) Wenwen Yue et al. Nature Communications
- Cancer nanomedicine for combination cancer immunotherapy
- (2019) Jutaek Nam et al. Nature Reviews Materials
- Enzyme-Driven Membrane-Targeted Chimeric Peptide for Enhanced Tumor Photodynamic Immunotherapy
- (2019) Chi Zhang et al. ACS Nano
- CSF1R‐ and SHP2‐Inhibitor‐Loaded Nanoparticles Enhance Cytotoxic Activity and Phagocytosis in Tumor‐Associated Macrophages
- (2019) Anujan Ramesh et al. ADVANCED MATERIALS
- Targeting SHP2 as a promising strategy for cancer immunotherapy
- (2019) Qianqian Liu et al. PHARMACOLOGICAL RESEARCH
- Enhanced Immunotherapy Based on Photodynamic Therapy for Both Primary and Lung Metastasis Tumor Eradication
- (2018) Wen Song et al. ACS Nano
- SHP2 inhibition restores sensitivity in ALK-rearranged non-small-cell lung cancer resistant to ALK inhibitors
- (2018) Leila Dardaei et al. NATURE MEDICINE
- Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases
- (2016) Ying-Nan P. Chen et al. NATURE
- Induced protein degradation: an emerging drug discovery paradigm
- (2016) Ashton C. Lai et al. NATURE REVIEWS DRUG DISCOVERY
- Core-shell nanoscale coordination polymers combine chemotherapy and photodynamic therapy to potentiate checkpoint blockade cancer immunotherapy
- (2016) Chunbai He et al. Nature Communications
- SCF ubiquitin ligase-targeted therapies
- (2014) Jeffrey R. Skaar et al. NATURE REVIEWS DRUG DISCOVERY
- Diversity of degradation signals in the ubiquitin–proteasome system
- (2008) Tommer Ravid et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search